Predict your next investment

Corporation
HEALTHCARE | Drug Development
akebia.com

See what CB Insights has to offer

Founded Year

2007

Stage

PIPE | IPO

Total Raised

$95.34M

Market Cap

0.47B

Stock Price

2.67

About Akebia Therapeutics

Akebia Therapeutics is focused on discovering and developing therapeutic solutions leveraging the potential of the hypoxia-inducible factor - or HIF - biology. HIF-Prolyl Hydroxylase inhibition could represent an approach to treating certain conditions where there is an unmet need.

Akebia Therapeutics Headquarter Location

245 First Street Suite 1400

Cambridge, Massachusetts, 02142,

United States

617-871-2098

Latest Akebia Therapeutics News

08:30 ET Akebia Therapeutics Announces Participation in Upcoming Investor Conferences

Nov 24, 2021

News provided by Share this article Share this article CAMBRIDGE, Mass., Nov. 24, 2021 /PRNewswire/ --  Akebia Therapeutics, Inc.  (Nasdaq: AKBA ), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John P. Butler, Chief Executive Officer, and David A. Spellman, Chief Financial Officer, will participate in the following investor conferences: Piper Sandler 33rd Annual Virtual Healthcare Conference November 29 – December 2, 2021 John Butler will participate in a virtual fireside chat, which will be available on the conference site prior to the virtual event. 4th Annual Evercore ISI HealthCONx Conference November 30 - December 2, 2021 John Butler will participate in a virtual fireside chat, which will be presented on Tuesday, November 30 at 4:45 on the conference site. Where applicable, webcasts of Akebia's fireside chats will be made available on the Investors section of the Company's website at https://ir.akebia.com . About Akebia Therapeutics Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com , which does not form a part of this release. Akebia Therapeutics Contact

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Akebia Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Akebia Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Akebia Therapeutics Patents

Akebia Therapeutics has filed 30 patents.

The 3 most popular patent topics include:

  • Transcription factors
  • Acetic acids
  • Pyridines
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/10/2020

7/20/2021

Hepatotoxins, Acetic acids, Metal halides, Pyridines, Carboxamides

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/10/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/20/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Hepatotoxins, Acetic acids, Metal halides, Pyridines, Carboxamides

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Akebia Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Akebia Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.